Charles River Laboratories (CRL) — Strategic Asset Allocation Index
Charles River Laboratories (CRL) has a Strategic Asset Allocation Index of 62.6% as of September 2025. Strategic assets (PP&E of $1.97 Billion plus long-term investments of $194.63 Million) total $2.16 Billion, measured against net assets of $3.45 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Charles River Laboratories Strategic Asset Allocation Index (2000–2024)
This chart shows how Charles River Laboratories's Strategic Asset Allocation Index has evolved across 25 annual periods from 2000 to 2024. As of September 2025, the index stands at 62.6%, representing strategic assets of $2.16 Billion against net assets of $3.45 Billion USD. Explore Charles River Laboratories cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Charles River Laboratories (2000–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Charles River Laboratories from 2000 to 2024, covering 25 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Charles River Laboratories market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 63.7% | $2.23 Billion | $2.02 Billion | $218.35 Million | $3.51 Billion | ▲ +1.5 pp |
| 2023 | 62.2% | $2.28 Billion | $2.03 Billion | $243.81 Million | $3.66 Billion | ▼ -9.5 pp |
| 2022 | 71.7% | $2.17 Billion | $1.86 Billion | $311.60 Million | $3.02 Billion | ▲ +2.9 pp |
| 2021 | 68.9% | $1.79 Billion | $1.58 Billion | $201.35 Million | $2.59 Billion | ▲ +6.1 pp |
| 2020 | 62.8% | $1.35 Billion | $1.12 Billion | $221.80 Million | $2.14 Billion | ▼ -7.2 pp |
| 2019 | 70.0% | $1.17 Billion | $1.04 Billion | $122.98 Million | $1.67 Billion | ▼ -6.3 pp |
| 2018 | 76.3% | $1.02 Billion | $932.88 Million | $88.59 Million | $1.34 Billion | ▼ -3.8 pp |
| 2017 | 80.2% | $853.07 Million | $781.97 Million | $71.10 Million | $1.06 Billion | ▼ -13.7 pp |
| 2016 | 93.8% | $801.16 Million | $755.83 Million | $45.33 Million | $853.78 Million | ▲ +1.0 pp |
| 2015 | 92.8% | $710.69 Million | $677.96 Million | $32.73 Million | $765.56 Million | ▼ -7.1 pp |
| 2014 | 99.9% | $703.84 Million | $676.80 Million | $27.05 Million | $704.35 Million | ▼ -1.8 pp |
| 2013 | 101.7% | $676.18 Million | $676.18 Million | $- | $664.66 Million | ▼ -17.1 pp |
| 2012 | 118.9% | $717.02 Million | $717.02 Million | $- | $603.20 Million | ▼ -20.6 pp |
| 2011 | 139.5% | $738.03 Million | $738.03 Million | $- | $529.14 Million | ▲ +30.2 pp |
| 2010 | 109.3% | $752.66 Million | $752.66 Million | $- | $688.73 Million | ▲ +46.3 pp |
| 2009 | 63.0% | $865.74 Million | $865.74 Million | $- | $1.37 Billion | ▼ -6.1 pp |
| 2008 | 69.1% | $828.92 Million | $828.92 Million | $- | $1.20 Billion | ▲ +28.9 pp |
| 2007 | 40.2% | $748.79 Million | $748.79 Million | $- | $1.86 Billion | ▲ +6.8 pp |
| 2006 | 33.3% | $534.75 Million | $534.75 Million | $- | $1.60 Billion | ▲ +11.6 pp |
| 2005 | 21.7% | $399.45 Million | $399.45 Million | $- | $1.84 Billion | ▼ -2.3 pp |
| 2004 | 24.1% | $357.15 Million | $357.15 Million | $- | $1.48 Billion | ▼ -18.8 pp |
| 2003 | 42.9% | $203.46 Million | $203.46 Million | $- | $474.80 Million | ▼ -7.1 pp |
| 2002 | 50.0% | $187.88 Million | $187.88 Million | $- | $375.94 Million | ▼ -1.6 pp |
| 2001 | 51.5% | $155.92 Million | $155.92 Million | $- | $302.50 Million | ▼ -38.3 pp |
| 2000 | 89.8% | $117.00 Million | $117.00 Million | $- | $130.26 Million | — |